Background: Acute coronary syndrome encompasses unstable angina, non–ST-elevation myocardial infarction, and ST-elevation myocardial infarction. Coronary artery disease stands as the leading cause of death worldwide. The condition is not typically suspected in young individuals, particularly those without a substantial family history. Hyperhomocysteinemia and elevated lipoprotein(a) levels are recognized as significant risk factors and can be integrated into screening tools for early identification and intervention.
Case Presentation: A 23-year-old man was diagnosed with an evolved anterior wall myocardial infarction, verified through ECG and echocardiography. Further investigation using coronary angiography revealed a single-vessel disease with the involvement of branch vessels, which was treated successfully via bifurcation stenting. Optical coherence tomography analysis of the lesion indicated a fibrous-atheromatous lesion accompanied by thrombosis. Upon evaluation, high lipoprotein(a) and hyperhomocysteinemia were identified as risk factors contributing to the patient’s condition.
Conclusions: Lipoprotein(a) and familial hyperhomocysteinemia should not be exclusively linked to a family history of premature atherosclerotic cardiovascular disease (ASCVD). These factors should be considered important in screening due to their significant impact on ASCVD risk. Furthermore, intracoronary imaging should be employed extensively to gain insights into the pathophysiology of the disease and enhance interventional strategies in these situations. (Iranian Heart Journal 2025; 26(1): 113-121)
Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937–952. 2004/09/15. DOI:10.1016/s0140-6736(04)17018-9.
Agrawal A, Lamichhane P, Eghbali M, Xavier R, Cook DE, Elsherbiny RM, Jhajj LK, Khanal R. Risk factors, lab parameters, angiographic characteristics and outcomes of coronary artery disease in young South Asian patients: a systematic review. J Int Med Res. 2023 Aug; 51(8):3000605231187806. doi:10.1177/03000605231187806. PMID:37555333; PMCID: PMC10413899.
Tripathi R, Tewari S, Singh PK, Agarwal S. Association of homocysteine and methylene tetrahydrofolate reductase (MTHFR C677T) gene polymorphism with coronary artery disease (CAD) in the population of North India. Genet Mol Biol. 2010 Apr; 33(2):224-8. doi:10.1590/S1415-47572010005000026. Epub 2010 Jun 1. PMID: 21637473; PMCID: PMC3036870.
Mohan V, Deepa R, Haranath SP, Premalatha G, Rema M, Sastry NG, Enas EA. Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India. Diabetes Care. 1998 Nov;21(11):1819-23. doi:10.2337/diacare.21.11.1819. PMID:9802727.
Tsimikas S, Stroes ESG. The dedicated “Lp(a) clinic”: A concept whose time has arrived? Atherosclerosis. 2020 May;300:1-9. doi:10.1016/j.atherosclerosis.2020.03.003. Epub 2020 Mar 13. PMID: 32234580.
Haring B, von Ballmoos MC, Appel LJ, Sacks FM. Healthy dietary interventions and lipoprotein (a) plasma levels: results from the Omni Heart Trial. PLoS One. 2014 Dec 15;9(12):e114859. doi:10.1371/journal.pone.0114859. PMID:25506933; PMCID: PMC4266632.
Guthikonda S, Haynes WG. Homocysteine: role and implications in atherosclerosis. Curr Atheroscler Rep. 2006 Mar; 8(2):100-6. doi:10.1007/s11883-006-0046-4. PMID:16510043.
Martí-Carvajal AJ, Solà I, Lathyris D, Dayer M. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2017 Aug 17; 8(8): CD006612. Doi:10.1002/14651858.CD006612.pub5. PMID: 28816346; PMCID: PMC6483699.
Huo Y, Li J, Qin X, Huang Y, Wang X, Gottesman RF, Tang G, Wang B, Chen D, He M, Fu J, Cai Y, Shi X, Zhang Y, Cui Y, Sun N, Li X, Cheng X, Wang J, Yang X, Yang T, Xiao C, Zhao G, Dong Q, Zhu D, Wang X, Ge J, Zhao L, Hu D, Liu L, Hou FF; CSPPT Investigators. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomised clinical trial. JAMA. 2015 Apr 7; 313(13):1325-35. doi: 10.1001/jama.2015.2274. PMID: 25771069.
Saha,R. , Duggal,B. and Chawla,R. (2025). Double-Trouble Hyperhomocysteinemia and Lipoprotein(a)-Induced Myocardial Infarction in a Very Young Man: A Case Report. Iranian Heart Journal, 26(1), 113-121.
MLA
Saha,R. , , Duggal,B. , and Chawla,R. . "Double-Trouble Hyperhomocysteinemia and Lipoprotein(a)-Induced Myocardial Infarction in a Very Young Man: A Case Report", Iranian Heart Journal, 26, 1, 2025, 113-121.
HARVARD
Saha R., Duggal B., Chawla R. (2025). 'Double-Trouble Hyperhomocysteinemia and Lipoprotein(a)-Induced Myocardial Infarction in a Very Young Man: A Case Report', Iranian Heart Journal, 26(1), pp. 113-121.
CHICAGO
R. Saha, B. Duggal and R. Chawla, "Double-Trouble Hyperhomocysteinemia and Lipoprotein(a)-Induced Myocardial Infarction in a Very Young Man: A Case Report," Iranian Heart Journal, 26 1 (2025): 113-121,
VANCOUVER
Saha R., Duggal B., Chawla R. Double-Trouble Hyperhomocysteinemia and Lipoprotein(a)-Induced Myocardial Infarction in a Very Young Man: A Case Report. Iranian Heart Journal, 2025; 26(1): 113-121.